Cardiff Oncology, Inc.

US$0.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRDFHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (43.63%)
Div yield —
ROE (94.08%)
Biotechnology
Beta (5Y) 1.56
PE TTM —
TSR TTM (66.16%)
Mkt cap US$61.87M
ROIC (60.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.02
28.29%
(53.13%)
Hold 2|8|5|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
29.32%
23.94%
23.39%
21.31%
Revenue$M
4.318
4.339
4.378
4.596
3.92%
3.93%
6.30%
7.58%
Peers (US$61.87M)
Cap (US$)
PE
61.95M
—
61.70M
0.569x
61.82M
—
Capital
TTM
5Y
10Y
Leveragex
0.427
2.494
2.136
EBIT/Intx
1.612
0.137
0.112
Own earn%
(60.80)
(83.58)
(93.63)
Sh yield%
42.98
34.43
35.22
Owners
Insiders/Inst%
3.94
89.75
Short interest%
1.59
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
23–27
$1 testx
—
Incr. ROIC%
8